DNA damage-free iPS cells exhibit potential to yield competent cardiomyocytes
- 14 February 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 318 (4), H801-H815
- https://doi.org/10.1152/ajpheart.00658.2019
Abstract
DNA damage accrued in iPS-derived cardiomyocytes (iPS-CMs) during in vitro culture practices lessens their clinical potentials for therapy. We determined whether DNA damage-free iPSCs (DdF-iPS) can be selected using stabilization of p53, transcription factor that promotes apoptosis in DNA damaged cells, and differentiate them into functionally competent DdF-cardiomyocytes (DdF-CM). p53 was activated using Nutlin-3a in iPSCs to selectively kill the DNA damaged cells, and the stable DdF cells were cultured further and differentiated into CM. Both DdF-iPSCs and DdF-CMs were then characterized. We observed a significant decrease in the expression of reactive oxygen species (ROS) and DNA damage in DdF-iPSCs compared to control (Ctrl)-iPSCs. Next-generation RNA sequencing and Ingenuity pathway analysis revealed improved molecular, cellular, and physiological functions in DdF-iPSCs. The differentiated DdF-CMs had a compact beating frequency between 40 to 60 beats per minute accompanied by increased cell surface area. Additionally, DdF-CMs were able to retain the improved molecular, cellular, and physiological functions after differentiation from iPSCs, and interestingly, cardiac development network was prominent compared to Ctrl-CMs. Enhanced expression of various ion channel transcripts in DdF-CMs implies DdF-CMs is of ventricular CMs and matured compared to its counterpart. Our results indicated that DdF-iPSCs could be selected through p53 stabilization using small molecule and differentiated into ventricular DdF-CMS with fine-tuned molecular signatures. These iPS cells derived DdF-CMs shows immense clinical potential in repairing injured myocardium.Funding Information
- HHS | NIH | National Heart, Lung, and Blood Institute (RO1 HL 95077, HL114120, HL 131017, HL138023, UO1 HL134764, 1R01HL118067, 2R01HL118067)
- American Heart Association (17SDG33670677)
This publication has 43 references indexed in Scilit:
- DNA double‐strand break response in stem cells: Mechanisms to maintain genomic integrityBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Distinct Roles of MicroRNA-1 and -499 in Ventricular Specification and Functional Maturation of Human Embryonic Stem Cell-Derived CardiomyocytesPLOS ONE, 2011
- Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemiaBlood, 2006
- Differential expression of small-conductance Ca2+-activated K+channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad NeighborsCell, 2005
- Oxygen sensitivity severely limits the replicative lifespan of murine fibroblastsNature, 2003
- Cellular senescence as a tumor-suppressor mechanismTrends in Cell Biology, 2001
- Differential Distribution of Inward Rectifier Potassium Channel Transcripts in Human Atrium Versus VentricleCirculation, 1998
- Small-Conductance, Calcium-Activated Potassium Channels from Mammalian BrainScience, 1996
- Molecular cloning and functional expression of a novel brain‐specific inward rectifier potassium channelFEBS Letters, 1994